GlassScriptPhysician profile
Rory B Snepar
NPI 1609161322
$97,217.54
in general payments reported to CMS, 2019-2025
30 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $268 · 2021: $1,723 · 2022: $6,996 · 2023: $4,198 · 2024: $30K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Education: $13K · Food and Beverage: $11K · Travel and Lodging: $7,078 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,900 · Long Term Medical Supply Or Device Loan: $1,347 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,825.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,600.00 |
| Education | $13,000.00 |
| Food and Beverage | $10,762.03 |
| Travel and Lodging | $7,077.63 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,900.00 |
| Long Term Medical Supply Or Device Loan | $1,347.00 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $34,741.99 | 2023-2025 | Celleraterx, Celleraterx, Biasurge |
| Convatec INC. | $27,406.73 | 2024-2025 | |
| Intuitive Surgical, INC. | $22,002.21 | 2022-2025 | Da Vinci Surgical System |
| Davol INC. | $2,979.61 | 2020-2025 | Phasix Mesh, Arista Ah Flexitip, Bard 3dmax Mesh |
| Integra Lifesciences Corporation | $2,878.20 | 2021-2024 | Integra, Acell, Integra Dermal Regeneration Template |
| Kerecis Limited | $2,587.42 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $1,101.55 | 2019-2025 | Pico 14, Pico 7, Pico |
| Musculoskeletal Transplant Foundation INC. | $1,046.64 | 2021-2025 | |
| Becton, Dickinson and Company | $584.15 | 2019-2024 | Phasix Mesh |
| Allergan, INC. | $279.04 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $154.07 | 2025 | Gore Synecor Preperitoneal Biomaterial |
| Depuy Synthes Sales INC. | $149.89 | 2022 | |
| Ethicon US, LLC | $143.23 | 2020-2021 | |
| Innovation Technologies INC | $141.09 | 2021 | |
| Abbvie INC. | $127.49 | 2022-2024 | Strattice Reconstructive Tissue Matrix Bps |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $115.48 | 2022 | |
| Hologic Sales and Service, LLC | $112.57 | 2025 | Coolseal Generator |
| Biom'Up Sa | $110.48 | 2019 | |
| Acadia Pharmaceuticals INC | $96.00 | 2019 | |
| Innocoll Pharmaceuticals Limited | $93.96 | 2021-2022 | |
| Biotissue Holdings INC. | $93.46 | 2024 | |
| Revance Therapeutics, INC. | $71.77 | 2024 | Daxxify |
| Dilon Technologies, INC. | $40.75 | 2024 | Hemoblast Bellows |
| Misonix INC | $27.69 | 2020-2021 | |
| Tela Bio, INC. | $27.48 | 2021 | |
| Conmed Corporation | $26.20 | 2025 | Airseal |
| Takeda Pharmaceuticals U.S.A., INC. | $25.86 | 2021 | |
| Organogenesis INC. | $20.00 | 2022 | |
| Acera Surgical, INC. | $18.83 | 2025 | Restrata Wound Matrix |
| Hydrofera LLC | $13.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rory Snepar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.